Literature DB >> 22881285

Association study of a polymorphism in clock gene PERIOD3 and risk of inflammatory bowel disease.

Gianluigi Mazzoccoli1, Orazio Palmieri, Giuseppe Corritore, Tiziana Latiano, Fabrizio Bossa, Daniela Scimeca, Giuseppe Biscaglia, Maria Rosa Valvano, Renata D'Incà, Salvatore Cucchiara, Laura Stronati, Vito Annese, Angelo Andriulli, Anna Latiano.   

Abstract

Altered body rhythmicity and deregulated clock gene expression may cause circadian disruption, which can lead to immune dysregulation and chronic inflammatory diseases. PERIOD3 (PER3) polymorphisms have been associated with circadian disruption and changed secretion of cytokines involved in chronic inflammation. Crohn's disease (CD) and ulcerative colitis (UC) are multifactorial diseases resulting from complex interaction among environmental/microbial factors and the intestinal immune system, triggering an abnormal immune response in genetically susceptible individuals. We evaluated the influence of a polymorphism of the clock gene PER3 on susceptibility and behavior of these inflammatory bowel diseases. The rs2797685 variant of the PER3 gene was assessed in 1082 CD and 972 UC patients, 754 of whom had been diagnosed <18 yrs of age, and 1311 unrelated healthy controls. Allele and genotype frequencies of rs2797685 were significantly increased in both CD (p = 1.6 × 10(-4), odds ratio [OR] = 1.38, 95% confidence interval [CI]: 1.17-1.63) and UC (p = .012, OR = 1.25, 95% CI: 1.05-1.48) patients. Difference between frequency distributions remained statistically significant after stratifying the cohort according to age at diagnosis for CD, but not for UC. Statistically significant association was found between PER3 polymorphism and use of immunosuppressive drugs in pediatric CD patients (p < .001) and with stricturing and fistulizing disease behavior in adult CD patients (p = .031). In conclusion, results of this association study suggest a possible role of PER3 polymorphism in determining susceptibility to CD and UC and phenotypic characteristics of CD. In particular, the rs2797685 variant of the PER3 gene is associated with a more aggressive form of CD, highlighted by higher use of immunosuppressants and more frequent stricturing and fistulizing disease behaviors, as well as early onset of CD. This is a descriptive study, and functional data are needed to prove a causal relationship; nonetheless, involvement of the clock gene machinery in the susceptibility and the behavior of inflammatory bowel diseases may suggest new pathophysiological mechanisms and new therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22881285     DOI: 10.3109/07420528.2012.705935

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  17 in total

1.  Circadian rhythm disruption impairs tissue homeostasis and exacerbates chronic inflammation in the intestine.

Authors:  René Pagel; Florian Bär; Torsten Schröder; Annika Sünderhauf; Axel Künstner; Saleh M Ibrahim; Stella E Autenrieth; Kathrin Kalies; Peter König; Anthony H Tsang; Dominik Bettenworth; Senad Divanovic; Hendrik Lehnert; Klaus Fellermann; Henrik Oster; Stefanie Derer; Christian Sina
Journal:  FASEB J       Date:  2017-07-14       Impact factor: 5.191

Review 2.  Circadian clock circuitry in colorectal cancer.

Authors:  Gianluigi Mazzoccoli; Manlio Vinciguerra; Gennaro Papa; Ada Piepoli
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 3.  Circadian clocks in the digestive system.

Authors:  Anneleen Segers; Inge Depoortere
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-02       Impact factor: 46.802

4.  Changes in Clock Genes Expression in Esophagus in Rat Reflux Esophagitis.

Authors:  Atsushi Hashimoto; Risa Uemura; Akinari Sawada; Yuji Nadatani; Koji Otani; Shuhei Hosomi; Yasuaki Nagami; Fumio Tanaka; Noriko Kamata; Koichi Taira; Hirokazu Yamagami; Tetsuya Tanigawa; Toshio Watanabe; Yasuhiro Fujiwara
Journal:  Dig Dis Sci       Date:  2019-02-28       Impact factor: 3.199

5.  Case-control study of candidate gene methylation and adenomatous polyp formation.

Authors:  M Alexander; J B Burch; S E Steck; C-F Chen; T G Hurley; P Cavicchia; N Shivappa; J Guess; H Zhang; S D Youngstedt; K E Creek; S Lloyd; K Jones; J R Hébert
Journal:  Int J Colorectal Dis       Date:  2016-10-22       Impact factor: 2.571

Review 6.  Circadian rhythms: a regulator of gastrointestinal health and dysfunction.

Authors:  Robin M Voigt; Christopher B Forsyth; Ali Keshavarzian
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2019-03-25       Impact factor: 3.869

Review 7.  Crosstalk between the circadian clock circuitry and the immune system.

Authors:  Nicolas Cermakian; Tanja Lange; Diego Golombek; Dipak Sarkar; Atsuhito Nakao; Shigenobu Shibata; Gianluigi Mazzoccoli
Journal:  Chronobiol Int       Date:  2013-05-22       Impact factor: 2.877

8.  Chronotype, social jet lag, sleep debt and food timing in inflammatory bowel disease.

Authors:  Prachi S Chakradeo; Ali Keshavarzian; Shubha Singh; Akram E Dera; James Philip G Esteban; Alice A Lee; Helen J Burgess; Louis Fogg; Garth R Swanson
Journal:  Sleep Med       Date:  2018-08-17       Impact factor: 3.492

9.  Case-control study of the PERIOD3 clock gene length polymorphism and colorectal adenoma formation.

Authors:  Melannie Alexander; James B Burch; Susan E Steck; Chin-Fu Chen; Thomas G Hurley; Philip Cavicchia; Meredith Ray; Nitin Shivappa; Jaclyn Guess; Hongmei Zhang; Shawn D Youngstedt; Kim E Creek; Stephen Lloyd; Xiaoming Yang; James R Hébert
Journal:  Oncol Rep       Date:  2014-12-11       Impact factor: 3.906

10.  Interaction between retinoid acid receptor-related orphan receptor alpha (RORA) and neuropeptide S receptor 1 (NPSR1) in asthma.

Authors:  Nathalie Acevedo; Annika Sääf; Cilla Söderhäll; Erik Melén; Jami Mandelin; Christina Orsmark Pietras; Sini Ezer; Piia Karisola; Johanna Vendelin; Gustav Boije af Gennäs; Jari Yli-Kauhaluoma; Harri Alenius; Erika von Mutius; Gert Doekes; Charlotte Braun-Fahrländer; Josef Riedler; Marianne van Hage; Mauro D'Amato; Annika Scheynius; Göran Pershagen; Juha Kere; Ville Pulkkinen
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.